Highlights in diagnostics and management of rheumatoid arthritis.

Abstract

In rheumatoid arthritis detection of antibodies to cyclic citrulinated peptide belong to the novel diagnostic tests. Early morphological changes can be observed using ultrasonography or magnetic resonance imaging.

Biologicals represent novel therapeutic option.

Keywords

• rheumatoid arthritis
• cyclic citrulinated peptide
• ultrasonography
• magnetic resonance